期刊文献+

高效液相色谱-串联质谱法测定移植患者血浆泊沙康唑水平 被引量:3

Determination of plasma posaconazole level in transplant patient by HPLC-MS/MS
下载PDF
导出
摘要 目的建立测定血浆泊沙康唑水平的高效液相色谱-串联质谱(HPLC-MS/MS)法,并应用于临床治疗药物监测。方法 HPLC色谱柱为Ultimate XB-C18。柱温50℃,流速0.8mL/min,流动相为含0.1%甲酸,以及2mmol/L乙酸铵的水溶液和含0.1%甲酸的甲醇溶液,梯度洗脱。质谱检测方式为ESI正离子模式,MRM扫描,监测泊沙康唑m/z 701.5~683.4作为定量离子,内标泊沙康唑-d4m/z 705.4~687.5作为定量离子。结果泊沙康唑水平在0.1~10.0μg/L范围内与峰面积线性关系良好(r=0.993 0),日内及日间精密度<5%,平均回收率为90%~103%。结论该方法简便、准确、快速,适用于泊沙康唑的血药浓度测定。 Objective To establish a HPLC-MS/MS method for determing of plasma posaconazole level in transplant patient,and to apply it in the drug monitoring of clinical treatment. Methods The HPLC chromatographic column was Ultimate XB-C18 column,the column temperature was 50 ℃,the flow rate was 0.8 mL/min,the mobile phase was the aqueous solution containing 2 mmol/L lammonium acetate and 0.1% formic acid,and methanol solution containing 0.1% formic acid.The gradient elution was performed.The mass spectrum detection method was ESI positive ion mode,MRM scanning,monitoring posaconazole m/z 701.5- 683.4 served as quantitative ion.The internal standard substance posaconazole-d4 m/z 705.4-687.5 served as quantitative ion. Results The posaconazole level had good linear relation with the peak area during the range of 0.1- 10 μg/L ( r =0.993 0).The intra- and inter-day precision 〈5%,the average recovery rate was 90%-103%. Conclusion This method is convenient,accurate and rapid,and is suitable for the determination of posaconazole blood concentration.
作者 王磊 孙文利 刘红星 WANG Lei;SUN Wenli;LIU Hongxing(Hebei Yanda Lu Daopei Hospital,Langfang,Hebei 065201,China)
出处 《检验医学与临床》 CAS 2018年第19期2902-2905,共4页 Laboratory Medicine and Clinic
关键词 泊沙康唑 高效液相色谱-串联质谱 治疗药物监测 posaconazole HPLC-MS/MS drug monitoring
  • 相关文献

参考文献10

二级参考文献80

  • 1董彪,王钢,王伟刚,王远涛,周洪澜,傅耀文.肾移植术后间质性肺炎的早期诊断、预防及处理原则[J].实用器官移植电子杂志,2013,1(2):95-102. 被引量:6
  • 2潘晓鸣,薛武军,田普训,丁小明,燕航,冯新顺,项和立,侯军,丁晨光,李杨.肾移植三联免疫抑制剂应用合适剂量的探讨[J].实用器官移植电子杂志,2013,1(3):147-151. 被引量:7
  • 3李宁.肾移植术后贫血[J].实用器官移植电子杂志,2013,1(6). 被引量:1
  • 4罗永礼,白喜文.高龄患者肾移植60例次报告[J].中华器官移植杂志,1993,14(4):170-171. 被引量:5
  • 5陈丽娟.HPLC测定人血浆中伊曲康唑的浓度[J].华西药学杂志,2006,21(3):293-295. 被引量:10
  • 6Singh N. Trends in the epidemiology of opportunistic fungal infections:predisposing factors and the impact of antimicrobiaI use practices[J]. Clin Infect Dis,2001,33(15) : 1692- 1696.
  • 7Denning D W,Tueker R M,Hanson L H,et al. Treatment of invasive aspergillosis with itraconazole[J]. Am J Med, 1989, 86(6 Pt2) :791-800.
  • 8Tucker R M,Denning D W,Arathoon E G,et al. Itraconazote therapy for nonmeningeal coccidioidomycosis: clinical and lahoratory observations [J]. J Am Acad Dermatol, 1990, 23(3Pt 2):593 -601.
  • 9Denning D W, Tucker R M, Hanson I. H, et al. Itraconazole therapy for cryptococcal meningitis and cryptococcosis[J].Arch Intern Med,1989,149(10) :2301-2308.
  • 10Tricot G,Joosten E, Boogaerts M A, et al. Retoconazole vs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies[J].Rev Infect Dis, 1987,9(Suppl 1):S94-S99.

共引文献92

同被引文献20

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部